Literature DB >> 25333306

Liver computed tomographic perfusion in the assessment of microvascular invasion in patients with small hepatocellular carcinoma.

Dong Wu1, Ming Tan, Meiling Zhou, Huichuan Sun, Yuan Ji, Lingli Chen, Gang Chen, Mengsu Zeng.   

Abstract

OBJECTIVES: Detecting microvascular invasion (mVI) in patients with hepatocellular carcinoma is a diagnostic challenge. The present study aimed to acquire a series of quantitative perfusion parameters from liver computed tomography (CT) with a 320-slice scanner in patients with small hepatocellular carcinoma (sHCC) and study its efficacy in identifying mVI.
MATERIALS AND METHODS: Fifty-six patients who underwent hepatic resection for sHCC (≤3 cm) were preoperatively examined with a 320-detector row CT scanner. Histopathological analyses of liver biopsies confirmed that 18 patients had sHCC with mVI and that 38 patients had sHCC without mVI. Hepatic artery flow, portal vein flow (PVF), and perfusion index were measured in both tumor and normal liver tissues. Nonparametric receiver operating characteristic curve analysis was performed to quantify the accuracy of the perfusion CT parameters.
RESULTS: The tumor PVF (PVFtumor), difference in PVF between tumor and liver tissue (ΔPVF), and the ΔPVF/liver PVF ratio (rPVF) were significantly higher in sHCC with mVI than in sHCC without mVI (P = 0.0094, P = 0.0018, and P = 0.0007, respectively; Wilcoxon signed rank test). The PVFtumor, ΔPVF, and rPVF correctly predicted mVI in 73.2% (sensitivity, 66.7%; specificity, 76.3%; cutoff, 103.8 mL per 100 mL/min), 76.8% (sensitivity, 66.7%; specificity, 81.6%; cutoff, -53.65 mL per 100 mL/min), and 83.9% (sensitivity, 77.8%; specificity, 86.8%; cutoff, -0.38) of a total of 56 patients with sHCC, respectively. Other parameters were not significantly different between the groups.
CONCLUSIONS: Liver CT perfusion provides a noninvasive, quantitative method that can predict mVI in patients with sHCC through measurement of 3 perfusion parameters: PVFtumor, ΔPVF, and rPVF.

Entities:  

Mesh:

Year:  2015        PMID: 25333306     DOI: 10.1097/RLI.0000000000000098

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  11 in total

1.  Clinical evaluation of in silico planning and real-time simulation of hepatic radiofrequency ablation (ClinicIMPPACT Trial).

Authors:  Michael Moche; Harald Busse; Jurgen J Futterer; Camila A Hinestrosa; Daniel Seider; Philipp Brandmaier; Marina Kolesnik; Sjoerd Jenniskens; Roberto Blanco Sequeiros; Gaber Komar; Mika Pollari; Martin Eibisberger; Horst Rupert Portugaller; Philip Voglreiter; Ronan Flanagan; Panchatcharam Mariappan; Martin Reinhardt
Journal:  Eur Radiol       Date:  2019-08-30       Impact factor: 5.315

Review 2.  Updates on Imaging of Liver Tumors.

Authors:  Arya Haj-Mirzaian; Ana Kadivar; Ihab R Kamel; Atif Zaheer
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

3.  320-row CT renal perfusion imaging in patients with aortic dissection: A preliminary study.

Authors:  Dongting Liu; Jiayi Liu; Zhaoying Wen; Yu Li; Zhonghua Sun; Qin Xu; Zhanming Fan
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

4.  Limitations of predicting microvascular invasion in patients with hepatocellular cancer prior to liver transplantation.

Authors:  Michał Grąt; Jan Stypułkowski; Waldemar Patkowski; Emil Bik; Maciej Krasnodębski; Karolina M Wronka; Zbigniew Lewandowski; Michał Wasilewicz; Karolina Grąt; Łukasz Masior; Joanna Ligocka; Marek Krawczyk
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

5.  Preoperative computed tomography and serum α-fetoprotein to predict microvascular invasion in hepatocellular carcinoma.

Authors:  Wei Zhang; Lijuan Liu; Peng Wang; Lili Wang; Lidong Liu; Jie Chen; Danke Su
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

Review 6.  A Systematic Review on the Role of the Perfusion Computed Tomography in Abdominal Cancer.

Authors:  Nunzia Garbino; Valentina Brancato; Marco Salvatore; Carlo Cavaliere
Journal:  Dose Response       Date:  2021-11-24       Impact factor: 2.658

7.  Identification and Validation of a Prognostic Model Based on Three MVI-Related Genes in Hepatocellular Carcinoma.

Authors:  Yongchang Tang; Lei Xu; Yupeng Ren; Yuxuan Li; Feng Yuan; Mingbo Cao; Yong Zhang; Meihai Deng; Zhicheng Yao
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

8.  Value of MR histogram analyses for prediction of microvascular invasion of hepatocellular carcinoma.

Authors:  Ya-Qin Huang; He-Yue Liang; Zhao-Xia Yang; Ying Ding; Meng-Su Zeng; Sheng-Xiang Rao
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

9.  A prospective development study of software-guided radio-frequency ablation of primary and secondary liver tumors: Clinical intervention modelling, planning and proof for ablation cancer treatment (ClinicIMPPACT).

Authors:  Martin Reinhardt; Philipp Brandmaier; Daniel Seider; Marina Kolesnik; Sjoerd Jenniskens; Roberto Blanco Sequeiros; Martin Eibisberger; Philip Voglreiter; Ronan Flanagan; Panchatcharam Mariappan; Harald Busse; Michael Moche
Journal:  Contemp Clin Trials Commun       Date:  2017-08-18

10.  Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning.

Authors:  Yi-Quan Jiang; Su-E Cao; Shilei Cao; Jian-Ning Chen; Guo-Ying Wang; Wen-Qi Shi; Yi-Nan Deng; Na Cheng; Kai Ma; Kai-Ning Zeng; Xi-Jing Yan; Hao-Zhen Yang; Wen-Jing Huan; Wei-Min Tang; Yefeng Zheng; Chun-Kui Shao; Jin Wang; Yang Yang; Gui-Hua Chen
Journal:  J Cancer Res Clin Oncol       Date:  2020-08-27       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.